The GA mode of action in the treatment of multiple sclerosis is not fully elucidated [18], but it is beyond doubt that GA is modulating the immune response, which is also the case for several other antimicrobial peptides, including LL-37. This evidence concerns the gene CAMP and multiple sclerosis.